Directors' Shareholdings/Issue of equity

RNS Number : 2773M

Deltex Medical Group PLC

06 May 2015

 



 

 

Deltex Medical Group plc

Directors' Shareholdings/Issue of equity

6 May 2015 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 706,244 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 11 pence per share.

The four non-executive directors named below have elected to take 533,517 New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for respective periods to 31 March 2015.

A former non-executive director has elected to take 172,727 New Ordinary Shares in lieu of a cash payment as remuneration for his service to the Company for the period 13 June 2014 to 31 March 2015.

In addition to the above, the Company also announces that it was notified on 30 April 2015 that a number of former employees have acquired 100,893 ordinary shares of 1p each ("Option Shares"), as the result of the exercise of options under the Company's 2003 and 2013 Enterprise Management Incentive Schemes.

Accordingly, application has been made for the New Ordinary Shares and Option Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company. Admission to trading on AIM and dealings in the New Ordinary Shares and Option Shares are expected to commence on 12
May 2015.  Following the issue of these new shares the Company will have a total of 214,608,390 ordinary shares of 1p each in issue.

Following this issue, the relevant Directors' beneficial interests are as follows:

Name of Director	Period of service from	Number of New Ordinary Shares issued in lieu of fees/salary	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Nigel Keen	1 July 2014	227,270	8,722,524	4.06
Sir Duncan Nichol	1 July 2014	90,000	1,256,912	0.59
Julian Cazalet	1 July 2014	90,000	4,682,809	2.18
Mark Wippell	13 June 2014	126,247	126,247	0.06

In addition, the relevant former Director's beneficial interest is as follows:

Name of Director	Period of service from	Number of New Ordinary Shares issued in lieu of fees/salary	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Tim Irish	13 June 2014	172,727	3,021,211	1.41

For further information:

Deltex Medical Group plc	01243 774 837 [e-mail]
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Barry Curtis, Company Secretary
Nominated Adviser & Broker
Arden Partners plc	020 7614 5900
Chris Hardie
Joint Broker Zeus Capital Limited Phil Walker Dominic Wilson	020 7533 7727
Financial Public Relations
Newgate	020 7653 9850
Tim Thompson
Robyn McConnachie Ed Treadwell

 

END

 

 

RDSUGUWPAUPAPUA